Welcome to LookChem.com Sign In|Join Free

CAS

  • or

760981-83-7

Post Buying Request

760981-83-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

760981-83-7 Usage

Pharmaceutical Applications

A 2-fluoroketolide. The side chain substituting the C11–C12 carbamate is composed of a substituted triazolyl (aminophenyl) ring. It displays good in-vitro and in-vivo activity against Streptococcus spp., including Str. pneumoniae (MIC 0.0015–0.25 mg/L), Str. pyogenes (MIC ≤0.008–0.015 mg/L)and viridians group streptococci (MIC ≤0.008–0.06 mg/L). Activity against H. influenzae is close to that of azithromycin (MIC 1.0–2.0 mg/L). Vancomycin-susceptible strains of E. faecalis are inhibited by 0.003–2.0 mg/L and E. faecium by 0.25–2.0 mg/L. It exhibits good activity against Ch. pneumoniae (MIC 0.25–1.0 mg/L), C. trachomatis (MIC 0.123–0.5 mg/L) and Mycoplasma spp. (MIC ≤0.0008 mg/L). In vitro H. pylori is susceptible (MIC 0.006–0.25 mg/L), but C. jejuni less so (MIC 1–4 mg/L). It is extremely active in vitro against B. anthracis (MIC <0.008–0.015 mg/L) and other agents of bioterrorism such as Francisella tularensis (MIC <0.08–4.0 mg/L), Yersinia pestis and Burkholderia mallei (MIC 0.25–2.0 mg/L). It exhibits a good activity against the M. avium complex.In healthy adult volunteers the proposed therapeutic dose of 400 mg achieved a peak plasma concentration of 0.78 mg/L after 4 h. The apparent elimination half-life was 5.1 h.

Biological Activity

solithromycin (cem-101) is a new, potent and broad-spectrum fluoroketolide antibiotic [1][2].antibiotic is an antimicrobial used in the treatment and prevention of bacterial infection.solithromycin (cem-101) is a broad-spectrum fluoroketolide antibiotic. cem-101 exhibited high potency against diverse groups of gram-positive and gram-negative bacteria, including mycoplasma and ureaplasma, as well as bacteria associated with respiratory tract infections and skin infections, with mic50 values of 0.015 μg/ml and 4 μg/ml, respectively [1]. solithromycin (cem-101) bound to the large 50s subunit of the ribosome and inhibited protein biosynthesis. in streptococcus pneumoniae, staphylococcus aureus, and haemophilus influenzae, solithromycin inhibited cell viability, protein synthesis, and growth rate with ic50 values of 7.5, 40, and 125 ng/ml. solithromycin also inhibition the formation of the 50s subunit [3]. in monocytic u937 cells, solithromycin inhibited tnfα/cxcl8 production and mmp9 activity. in pbmc isolated from chronic obstructive pulmonary disease (copd) patients, solithromycin (10 μm) inhibited tnfα release and mmp9 activity. in monocytic u937 cells, solithromycin (10 μm) significantly inhibited nf-κb activity activated by oxidative stress [4].in c57bl/6j mice, solithromycin also inhibited cigarette smoke-induced neutrophilia and pro-mmp9 production [4]. cem-101 was also an effective antimicrobial for the prevention and treatment of intrauterine infection [2].

references

[1]. putnam sd, castanheira m, moet gj, et al. cem-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of gram-positive and gram-negative bacteria. diagn microbiol infect dis, 2010, 66(4): 393-401. [2]. keelan ja, kemp mw, payne ms, et al. maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model. antimicrob agents chemother, 2014, 58(1): 447-454.[3]. rodgers w, frazier ad, champney ws. solithromycin inhibition of protein synthesis and ribosome biogenesis in staphylococcus aureus, streptococcus pneumoniae, and haemophilus influenzae. antimicrob agents chemother, 2013, 57(4): 1632-1637.[4]. kobayashi y, wada h, rossios c, et al. a novel macrolide solithromycin exerts superior anti-inflammatory effect via nf-κb inhibition. j pharmacol exp ther, 2013, 345(1): 76-84.

Check Digit Verification of cas no

The CAS Registry Mumber 760981-83-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,0,9,8 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 760981-83:
(8*7)+(7*6)+(6*0)+(5*9)+(4*8)+(3*1)+(2*8)+(1*3)=197
197 % 10 = 7
So 760981-83-7 is a valid CAS Registry Number.

760981-83-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Solithromycin

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:760981-83-7 SDS

760981-83-7Synthetic route

C50H69FN6O11

C50H69FN6O11

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 40℃; for 24h;98%
With methanol at 40℃;97.7%
With methanol at 20℃; for 16h;0.2 g
1-(4-aminobutyl)-4-(3-aminophenyl)-1H-1,2,3-triazole

1-(4-aminobutyl)-4-(3-aminophenyl)-1H-1,2,3-triazole

C36H54FN3O12

C36H54FN3O12

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
With Imidazole hydrochloride at 60℃;95%
Stage #1: C36H54FN3O12 at 23℃; under 0.1 Torr; for 12h;
Stage #2: 1-(4-aminobutyl)-4-(3-aminophenyl)-1H-1,2,3-triazole With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 45℃; for 2h;
79 mg
11-N-(4-azido-butyl)-6-O-methyl-5-desosamynyl-3-oxo-2-fluoro-erythronolide A 11,12-carbamate

11-N-(4-azido-butyl)-6-O-methyl-5-desosamynyl-3-oxo-2-fluoro-erythronolide A 11,12-carbamate

3-acetylenephenylamine
54060-30-9

3-acetylenephenylamine

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
With copper(II) sulfate; sodium L-ascorbate In water; tert-butyl alcohol for 16h;69%
With copper(l) iodide In toluene at 70℃; for 16h;17 mg
With copper(II) sulfate; sodium L-ascorbate In water; tert-butyl alcohol at 20℃; for 24h;
With copper(II) sulfate; sodium L-ascorbate In water; tert-butyl alcohol at 20℃; for 24h; Reagent/catalyst; Huisgen Cycloaddition;
C48H82N2O18S

C48H82N2O18S

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: sodium azide / N,N-dimethyl-formamide / 15 h / 80 °C / Inert atmosphere
2.1: hydrogenchloride / methanol; water / 20 h / 20 °C
3.1: oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 1.5 h / -78 °C / Inert atmosphere
3.2: 2 h / -78 - 20 °C / Inert atmosphere
4.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
4.2: 2 h / 0 - 20 °C / Inert atmosphere
5.1: methanol / 3 h / Inert atmosphere; Reflux
6.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
C47H79N5O15
849407-73-4

C47H79N5O15

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: hydrogenchloride / methanol; water / 20 h / 20 °C
2.1: oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 1.5 h / -78 °C / Inert atmosphere
2.2: 2 h / -78 - 20 °C / Inert atmosphere
3.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
3.2: 2 h / 0 - 20 °C / Inert atmosphere
4.1: methanol / 3 h / Inert atmosphere; Reflux
5.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
acetic acid 2-[1-(4-azido-butyl)-4-ethyl-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-tetradecahydro-3,5-dioxa-1-aza-cyclopentacyclotetradecen-10-yloxy]-4-dimethylamino-6-methyl-tetrahydro-pyran-3-yl ester
849407-74-5

acetic acid 2-[1-(4-azido-butyl)-4-ethyl-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-tetradecahydro-3,5-dioxa-1-aza-cyclopentacyclotetradecen-10-yloxy]-4-dimethylamino-6-methyl-tetrahydro-pyran-3-yl ester

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 1.5 h / -78 °C / Inert atmosphere
1.2: 2 h / -78 - 20 °C / Inert atmosphere
2.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
2.2: 2 h / 0 - 20 °C / Inert atmosphere
3.1: methanol / 3 h / Inert atmosphere; Reflux
4.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
11-N-(4-azido-butyl)-6-O-methyl-5-(2-acetyl-desosamynyl)-3-oxo-erythronolide A 11,12-carbamate
760981-81-5

11-N-(4-azido-butyl)-6-O-methyl-5-(2-acetyl-desosamynyl)-3-oxo-erythronolide A 11,12-carbamate

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
1.2: 2 h / 0 - 20 °C / Inert atmosphere
2.1: methanol / 3 h / Inert atmosphere; Reflux
3.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
clarithromycin
81103-11-9

clarithromycin

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: dmap / dichloromethane / 18 h / 20 °C / Inert atmosphere
2.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / N,N-dimethyl-formamide / 72 h / 35 °C / Inert atmosphere
3.1: N,N-dimethyl-formamide / 48 h / 35 °C / Inert atmosphere
4.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C / Inert atmosphere
5.1: sodium azide / N,N-dimethyl-formamide / 15 h / 80 °C / Inert atmosphere
6.1: hydrogenchloride / methanol; water / 20 h / 20 °C
7.1: oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 1.5 h / -78 °C / Inert atmosphere
7.2: 2 h / -78 - 20 °C / Inert atmosphere
8.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
8.2: 2 h / 0 - 20 °C / Inert atmosphere
9.1: methanol / 3 h / Inert atmosphere; Reflux
10.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
Multi-step reaction with 10 steps
1.1: triethylamine / ethyl acetate / 24 h / 20 - 25 °C
2.1: hydrogenchloride / water; ethanol / 1.5 h
3.1: pyridine / dichloromethane / 1 h / -20 - 5 °C / Inert atmosphere
4.1: pyridinium chlorochromate / dichloromethane / 24 h / 20 °C
5.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / acetone / 24 h / 20 °C
6.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 1 h / -25 - -20 °C / Inert atmosphere
6.2: 1 h / -15 - -10 °C
7.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / acetonitrile / 55 - 65 °C
8.1: potassium tert-butylate / tetrahydrofuran / 1 h / -30 - -20 °C / Inert atmosphere
8.2: 1.5 h / -25 - -20 °C
9.1: N-ethyl-N,N-diisopropylamine; copper(l) iodide / acetonitrile / 20 °C / Inert atmosphere
10.1: methanol / 16 h / 20 °C
View Scheme
Multi-step reaction with 12 steps
1.1: triethylamine / ethyl acetate / 24 h / 20 - 25 °C
2.1: hydrogenchloride / water; ethanol / 1.5 h
3.1: pyridine / dichloromethane / 1 h / -20 - 5 °C / Inert atmosphere
4.1: pyridinium chlorochromate / dichloromethane / 24 h / 20 °C
5.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / acetone / 24 h / 20 °C
6.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 1 h / -25 - -20 °C / Inert atmosphere
6.2: 1 h / -15 - -10 °C
7.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / acetonitrile / 16 h / 55 - 60 °C
8.1: pyridine / 2 h / 0 - 10 °C
9.1: sodium azide / N,N-dimethyl-formamide / 8 h / 20 °C
10.1: potassium tert-butylate / tetrahydrofuran / 1 h / -30 - -20 °C / Inert atmosphere
10.2: 1.5 h / -25 - -20 °C
11.1: N-ethyl-N,N-diisopropylamine; copper(l) iodide / acetonitrile / 20 °C / Inert atmosphere
12.1: methanol / 16 h / 20 °C
View Scheme
Multi-step reaction with 7 steps
1.1: dmap; triethylamine / ethyl acetate / 16 h / 70 °C
2.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / toluene / 24.5 h / 28 °C
3.1: hydrogenchloride / acetone; water / 12 h / 40 °C
4.1: dimethylsulfide / dichloromethane / 4 h / -20 °C
4.2: 1.5 h / -20 - 25 °C
5.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane; dimethyl sulfoxide / 24 h / 25 °C
6.1: potassium tert-butylate / tetrahydrofuran / 0.17 h / -35 °C
6.2: 2 h / -35 - 25 °C
7.1: hydrogenchloride / water; methanol / 24 h / 40 °C
View Scheme
11-N-(4-azido-butyl)-6-O-methyl-5-(2-acetyl-desosamynyl)-3-oxo-2-fluoro-erythronolide A 11,12-carbamate

11-N-(4-azido-butyl)-6-O-methyl-5-(2-acetyl-desosamynyl)-3-oxo-2-fluoro-erythronolide A 11,12-carbamate

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: methanol / 3 h / Inert atmosphere; Reflux
2: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
2',4''-di-O-acetyl-6-O-methylerythromycin A
152235-55-7

2',4''-di-O-acetyl-6-O-methylerythromycin A

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / N,N-dimethyl-formamide / 72 h / 35 °C / Inert atmosphere
2.1: N,N-dimethyl-formamide / 48 h / 35 °C / Inert atmosphere
3.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C / Inert atmosphere
4.1: sodium azide / N,N-dimethyl-formamide / 15 h / 80 °C / Inert atmosphere
5.1: hydrogenchloride / methanol; water / 20 h / 20 °C
6.1: oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 1.5 h / -78 °C / Inert atmosphere
6.2: 2 h / -78 - 20 °C / Inert atmosphere
7.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
7.2: 2 h / 0 - 20 °C / Inert atmosphere
8.1: methanol / 3 h / Inert atmosphere; Reflux
9.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
10,11-anhydro-2',4''-di-O-acetyl-12-O-(imidazol-1-ylcarbonyl)-6-O-methylerythromycin A
217977-00-9

10,11-anhydro-2',4''-di-O-acetyl-12-O-(imidazol-1-ylcarbonyl)-6-O-methylerythromycin A

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: N,N-dimethyl-formamide / 48 h / 35 °C / Inert atmosphere
2.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C / Inert atmosphere
3.1: sodium azide / N,N-dimethyl-formamide / 15 h / 80 °C / Inert atmosphere
4.1: hydrogenchloride / methanol; water / 20 h / 20 °C
5.1: oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 1.5 h / -78 °C / Inert atmosphere
5.2: 2 h / -78 - 20 °C / Inert atmosphere
6.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
6.2: 2 h / 0 - 20 °C / Inert atmosphere
7.1: methanol / 3 h / Inert atmosphere; Reflux
8.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
C47H80N2O16
849407-71-2

C47H80N2O16

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C / Inert atmosphere
2.1: sodium azide / N,N-dimethyl-formamide / 15 h / 80 °C / Inert atmosphere
3.1: hydrogenchloride / methanol; water / 20 h / 20 °C
4.1: oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 1.5 h / -78 °C / Inert atmosphere
4.2: 2 h / -78 - 20 °C / Inert atmosphere
5.1: potassium tert-butylate / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
5.2: 2 h / 0 - 20 °C / Inert atmosphere
6.1: methanol / 3 h / Inert atmosphere; Reflux
7.1: copper(II) sulfate; sodium L-ascorbate / water; tert-butyl alcohol / 24 h / 20 °C
View Scheme
(R)-3-hydroxy-2-methylpent-1-ene
125637-07-2

(R)-3-hydroxy-2-methylpent-1-ene

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: 1H-imidazole / N,N-dimethyl-formamide / 24 h / 20 °C
2.1: sodium periodate; potassium osmate(VI) dihydrate; 2,6-dimethylpyridine / water; tetrahydrofuran / 3 h
3.1: lithium chloride / tetrahydrofuran / 1.1 h / -20 °C
4.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
5.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
7.1: 130 °C
8.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
8.2: 0.58 h / 23 °C
9.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
10.1: 12 h / 23 °C / 0.1 Torr
10.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 10 steps
1.1: 1H-imidazole / N,N-dimethyl-formamide / 24 h / 20 °C
2.1: sodium periodate; potassium osmate(VI) dihydrate; 2,6-dimethylpyridine / water; tetrahydrofuran / 3 h
3.1: lithium chloride / tetrahydrofuran / 1.1 h / -20 °C
4.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
5.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
7.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
8.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
8.2: 0.58 h / 23 °C
9.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
10.1: 12 h / 23 °C / 0.1 Torr
10.2: 2 h / 45 °C
View Scheme
(R)-tert-butyldimethyl((2-methylpent-1-en-3-yl)oxy)silane
135393-98-5

(R)-tert-butyldimethyl((2-methylpent-1-en-3-yl)oxy)silane

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: sodium periodate; potassium osmate(VI) dihydrate; 2,6-dimethylpyridine / water; tetrahydrofuran / 3 h
2.1: lithium chloride / tetrahydrofuran / 1.1 h / -20 °C
3.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
4.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
5.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
6.1: 130 °C
7.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
7.2: 0.58 h / 23 °C
8.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
9.1: 12 h / 23 °C / 0.1 Torr
9.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 9 steps
1.1: sodium periodate; potassium osmate(VI) dihydrate; 2,6-dimethylpyridine / water; tetrahydrofuran / 3 h
2.1: lithium chloride / tetrahydrofuran / 1.1 h / -20 °C
3.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
4.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
5.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
6.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
7.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
7.2: 0.58 h / 23 °C
8.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
9.1: 12 h / 23 °C / 0.1 Torr
9.2: 2 h / 45 °C
View Scheme
(R)-3-((tert-butyldimethylsilyl)oxy)pentan-2-one
220018-22-4

(R)-3-((tert-butyldimethylsilyl)oxy)pentan-2-one

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: lithium chloride / tetrahydrofuran / 1.1 h / -20 °C
2.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
3.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
4.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
5.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
6.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
6.2: 0.58 h / 23 °C
7.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
8.1: 12 h / 23 °C / 0.1 Torr
8.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 8 steps
1.1: lithium chloride / tetrahydrofuran / 1.1 h / -20 °C
2.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
3.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
4.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
5.1: 130 °C
6.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
6.2: 0.58 h / 23 °C
7.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
8.1: 12 h / 23 °C / 0.1 Torr
8.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 8 steps
1: lithium (1S,2R)-1-phenyl-2-(pyrrolidin-1-yl)-1-propanolate
2: bis(cyclopentadienyl)titanium dichloride; cyclopentylmagnesium bromide
3: Dess-Martin periodane
4: tetrabutyl ammonium fluoride
5: chlorobenzene / 132 °C
6: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
7: 1,8-diazabicyclo[5.4.0]undec-7-ene
8: Imidazole hydrochloride / 60 °C
View Scheme
C37H61N5O12

C37H61N5O12

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: methanol / 24 h / 23 °C
2.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
2.2: 1 h / -78 °C
3.1: sodium L-ascorbate; copper(II) sulfate / water; tert-butyl alcohol / 16 h
View Scheme
11-N-(4-azido-butyl)-6-O-methyl-5-O-desosaminyl-3-oxo-erythronolide A 11,12-carbamate
849407-75-6

11-N-(4-azido-butyl)-6-O-methyl-5-O-desosaminyl-3-oxo-erythronolide A 11,12-carbamate

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
1.2: 1 h / -78 °C
2.1: sodium L-ascorbate; copper(II) sulfate / water; tert-butyl alcohol / 16 h
View Scheme
(2R,4R)-5-((tert-butyldiphenylsilyl)oxy)-2-methoxy-2,4-dimethylpentanal

(2R,4R)-5-((tert-butyldiphenylsilyl)oxy)-2-methoxy-2,4-dimethylpentanal

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: magnesium bromide ethyl etherate / dichloromethane / 0.17 h / -78 - -10 °C
1.2: 12 h / -78 °C
2.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
3.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
4.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
5.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
6.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
7.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
8.1: 130 °C
9.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
9.2: 0.58 h / 23 °C
10.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
11.1: 12 h / 23 °C / 0.1 Torr
11.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 11 steps
1.1: magnesium bromide ethyl etherate / dichloromethane / 0.17 h / -78 - -10 °C
1.2: 12 h / -78 °C
2.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
3.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
4.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
5.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
6.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
7.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
8.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
9.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
9.2: 0.58 h / 23 °C
10.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
11.1: 12 h / 23 °C / 0.1 Torr
11.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 11 steps
1: zinc(II) chloride
2: silver trifluoromethanesulfonate
3: hydrogen fluoride / water
4: Dess-Martin periodane
5: bis(cyclopentadienyl)titanium dichloride; cyclopentylmagnesium bromide
6: Dess-Martin periodane
7: tetrabutyl ammonium fluoride
8: chlorobenzene / 132 °C
9: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
10: 1,8-diazabicyclo[5.4.0]undec-7-ene
11: Imidazole hydrochloride / 60 °C
View Scheme
C41H75NO12Si

C41H75NO12Si

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
2.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
3.1: 130 °C
4.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
4.2: 0.58 h / 23 °C
5.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
6.1: 12 h / 23 °C / 0.1 Torr
6.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 6 steps
1.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
2.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
3.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
4.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
4.2: 0.58 h / 23 °C
5.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
6.1: 12 h / 23 °C / 0.1 Torr
6.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 6 steps
1: Dess-Martin periodane
2: tetrabutyl ammonium fluoride
3: chlorobenzene / 132 °C
4: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
5: 1,8-diazabicyclo[5.4.0]undec-7-ene
6: Imidazole hydrochloride / 60 °C
View Scheme
C41H73NO12Si

C41H73NO12Si

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
2.1: 130 °C
3.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
3.2: 0.58 h / 23 °C
4.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
5.1: 12 h / 23 °C / 0.1 Torr
5.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 5 steps
1.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
2.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
3.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
3.2: 0.58 h / 23 °C
4.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
5.1: 12 h / 23 °C / 0.1 Torr
5.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 5 steps
1: tetrabutyl ammonium fluoride
2: chlorobenzene / 132 °C
3: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
4: 1,8-diazabicyclo[5.4.0]undec-7-ene
5: Imidazole hydrochloride / 60 °C
View Scheme
C35H59NO12

C35H59NO12

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
2.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
2.2: 0.58 h / 23 °C
3.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
4.1: 12 h / 23 °C / 0.1 Torr
4.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 4 steps
1.1: 130 °C
2.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
2.2: 0.58 h / 23 °C
3.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
4.1: 12 h / 23 °C / 0.1 Torr
4.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 4 steps
1: chlorobenzene / 132 °C
2: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
3: 1,8-diazabicyclo[5.4.0]undec-7-ene
4: Imidazole hydrochloride / 60 °C
View Scheme
C32H53NO11

C32H53NO11

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
1.2: 0.58 h / 23 °C
2.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
3.1: 12 h / 23 °C / 0.1 Torr
3.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 3 steps
1: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
2: 1,8-diazabicyclo[5.4.0]undec-7-ene
3: Imidazole hydrochloride / 60 °C
View Scheme
6-((2R,3R,4R,6R)-7-((tert-butyldiphenylsilyl)oxy)-3-hydroxy-4-methoxy-4,6-dimethylheptan-2-yl)-2,2,5-trimethyl-4H-1,3-dioxin-4-one

6-((2R,3R,4R,6R)-7-((tert-butyldiphenylsilyl)oxy)-3-hydroxy-4-methoxy-4,6-dimethylheptan-2-yl)-2,2,5-trimethyl-4H-1,3-dioxin-4-one

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
2.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
3.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
4.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
5.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
7.1: 130 °C
8.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
8.2: 0.58 h / 23 °C
9.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
10.1: 12 h / 23 °C / 0.1 Torr
10.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 10 steps
1.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
2.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
3.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
4.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
5.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
7.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
8.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
8.2: 0.58 h / 23 °C
9.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
10.1: 12 h / 23 °C / 0.1 Torr
10.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 10 steps
1: silver trifluoromethanesulfonate
2: hydrogen fluoride / water
3: Dess-Martin periodane
4: bis(cyclopentadienyl)titanium dichloride; cyclopentylmagnesium bromide
5: Dess-Martin periodane
6: tetrabutyl ammonium fluoride
7: chlorobenzene / 132 °C
8: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
9: 1,8-diazabicyclo[5.4.0]undec-7-ene
10: Imidazole hydrochloride / 60 °C
View Scheme
C32H52FNO11

C32H52FNO11

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
2.1: 12 h / 23 °C / 0.1 Torr
2.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 2 steps
1: 1,8-diazabicyclo[5.4.0]undec-7-ene
2: Imidazole hydrochloride / 60 °C
View Scheme
C51H77NO12Si

C51H77NO12Si

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: tetrabutyl ammonium fluoride / 130 °C
2.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
2.2: 0.58 h / 23 °C
3.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
4.1: 12 h / 23 °C / 0.1 Torr
4.2: 2 h / 45 °C
View Scheme
C43H65NO10Si

C43H65NO10Si

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
2.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
3.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
4.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
5.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
6.1: 130 °C
7.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
7.2: 0.58 h / 23 °C
8.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
9.1: 12 h / 23 °C / 0.1 Torr
9.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 9 steps
1.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
2.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
3.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
4.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
5.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
6.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
7.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
7.2: 0.58 h / 23 °C
8.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
9.1: 12 h / 23 °C / 0.1 Torr
9.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 9 steps
1: hydrogen fluoride / water
2: Dess-Martin periodane
3: bis(cyclopentadienyl)titanium dichloride; cyclopentylmagnesium bromide
4: Dess-Martin periodane
5: tetrabutyl ammonium fluoride
6: chlorobenzene / 132 °C
7: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
8: 1,8-diazabicyclo[5.4.0]undec-7-ene
9: Imidazole hydrochloride / 60 °C
View Scheme
C27H47NO10

C27H47NO10

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
2.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
3.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
4.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
5.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
6.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
6.2: 0.58 h / 23 °C
7.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
8.1: 12 h / 23 °C / 0.1 Torr
8.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 8 steps
1.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
2.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
3.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
4.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
5.1: 130 °C
6.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
6.2: 0.58 h / 23 °C
7.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
8.1: 12 h / 23 °C / 0.1 Torr
8.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 8 steps
1: Dess-Martin periodane
2: bis(cyclopentadienyl)titanium dichloride; cyclopentylmagnesium bromide
3: Dess-Martin periodane
4: tetrabutyl ammonium fluoride
5: chlorobenzene / 132 °C
6: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
7: 1,8-diazabicyclo[5.4.0]undec-7-ene
8: Imidazole hydrochloride / 60 °C
View Scheme
(2S,3R,4S,6R)-4-(dimethylamino)-2-(((2R,3R,4R,6R)-4-methoxy-4,6-dimethyl-7-oxo-2-(2,2,5-trimethyl-4-oxo-4H-1,3-dioxin-6-yl)heptan-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl methyl carbonate

(2S,3R,4S,6R)-4-(dimethylamino)-2-(((2R,3R,4R,6R)-4-methoxy-4,6-dimethyl-7-oxo-2-(2,2,5-trimethyl-4-oxo-4H-1,3-dioxin-6-yl)heptan-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl methyl carbonate

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
2.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
3.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
4.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
5.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
5.2: 0.58 h / 23 °C
6.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
7.1: 12 h / 23 °C / 0.1 Torr
7.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 7 steps
1.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
2.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
3.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
4.1: 130 °C
5.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
5.2: 0.58 h / 23 °C
6.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
7.1: 12 h / 23 °C / 0.1 Torr
7.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 7 steps
1: bis(cyclopentadienyl)titanium dichloride; cyclopentylmagnesium bromide
2: Dess-Martin periodane
3: tetrabutyl ammonium fluoride
4: chlorobenzene / 132 °C
5: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
6: 1,8-diazabicyclo[5.4.0]undec-7-ene
7: Imidazole hydrochloride / 60 °C
View Scheme
tert-butyl 2-methyl-3-oxopentanoate
26735-86-4

tert-butyl 2-methyl-3-oxopentanoate

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1.1: acetic anhydride; sulfuric acid / 5 h / 0 - 20 °C
2.1: n-butyllithium; N-ethyl-N,N-diisopropylamine / tetrahydrofuran / 1 h / -78 - 0 °C
2.2: 3 h / -78 - 20 °C
3.1: magnesium bromide ethyl etherate / dichloromethane / 0.17 h / -78 - -10 °C
3.2: 12 h / -78 °C
4.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
5.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
6.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
7.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
8.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
9.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
10.1: 130 °C
11.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
11.2: 0.58 h / 23 °C
12.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
13.1: 12 h / 23 °C / 0.1 Torr
13.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 13 steps
1.1: acetic anhydride; sulfuric acid / 5 h / 0 - 20 °C
2.1: n-butyllithium; N-ethyl-N,N-diisopropylamine / tetrahydrofuran / 1 h / -78 - 0 °C
2.2: 3 h / -78 - 20 °C
3.1: magnesium bromide ethyl etherate / dichloromethane / 0.17 h / -78 - -10 °C
3.2: 12 h / -78 °C
4.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
5.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
6.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
7.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
8.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
9.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
10.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
11.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
11.2: 0.58 h / 23 °C
12.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
13.1: 12 h / 23 °C / 0.1 Torr
13.2: 2 h / 45 °C
View Scheme
(2R,4R)-5-((tert-butyldiphenylsilyl)oxy)-2-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-methylpentan-2-ol

(2R,4R)-5-((tert-butyldiphenylsilyl)oxy)-2-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-methylpentan-2-ol

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1.1: potassium hydride / diethyl ether; mineral oil / 1 h / 0 °C
1.2: 2 h / 20 °C
2.1: periodic acid / ethyl acetate
3.1: magnesium bromide ethyl etherate / dichloromethane / 0.17 h / -78 - -10 °C
3.2: 12 h / -78 °C
4.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
5.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
6.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
7.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
8.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
9.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
10.1: 130 °C
11.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
11.2: 0.58 h / 23 °C
12.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
13.1: 12 h / 23 °C / 0.1 Torr
13.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 13 steps
1.1: potassium hydride / diethyl ether; mineral oil / 1 h / 0 °C
1.2: 2 h / 20 °C
2.1: periodic acid / ethyl acetate
3.1: magnesium bromide ethyl etherate / dichloromethane / 0.17 h / -78 - -10 °C
3.2: 12 h / -78 °C
4.1: silver trifluoromethanesulfonate / dichloromethane; toluene / 1 h / 0 °C / Molecular sieve
5.1: hydrogen fluoride / acetonitrile / 12 h / 20 °C
6.1: Dess-Martin periodane / dichloromethane; water / 0.5 h / 20 °C
7.1: bis(cyclopentadienyl)titanium dichloride; 2-methylpropylmagnesium chloride
8.1: Dess-Martin periodane / dichloromethane; water / 0.08 h / 22 °C
9.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1.5 h / 0 - 23 °C
10.1: chlorobenzene / 19.17 h / 23 - 150 °C / Inert atmosphere; Sonication
11.1: potassium tert-butylate / tetrahydrofuran / 0.08 h / -78 °C
11.2: 0.58 h / 23 °C
12.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1.5 h / -10 °C
13.1: 12 h / 23 °C / 0.1 Torr
13.2: 2 h / 45 °C
View Scheme
Multi-step reaction with 13 steps
1: potassium hydride
2: periodic acid
3: zinc(II) chloride
4: silver trifluoromethanesulfonate
5: hydrogen fluoride / water
6: Dess-Martin periodane
7: bis(cyclopentadienyl)titanium dichloride; cyclopentylmagnesium bromide
8: Dess-Martin periodane
9: tetrabutyl ammonium fluoride
10: chlorobenzene / 132 °C
11: potassium tert-butylate; N-fluorobis(benzenesulfon)imide
12: 1,8-diazabicyclo[5.4.0]undec-7-ene
13: Imidazole hydrochloride / 60 °C
View Scheme
(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

C42H63FN6O10

C42H63FN6O10

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate In dichloromethane at 20℃; for 24h;20%
(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

C103H122N10O20S

C103H122N10O20S

trifluoroacetic acid
76-05-1

trifluoroacetic acid

A

C146H185FN16O29S*C2HF3O2

C146H185FN16O29S*C2HF3O2

B

C146H185FN16O29S*C2HF3O2

C146H185FN16O29S*C2HF3O2

Conditions
ConditionsYield
Stage #1: (3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone; C103H122N10O20S With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 4h; Inert atmosphere;
Stage #2: trifluoroacetic acid In water; acetonitrile
A 16%
B 12%
(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone
760981-83-7

(3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone

C103H122N10O20S

C103H122N10O20S

trifluoroacetic acid
76-05-1

trifluoroacetic acid

A

C146H185FN16O29S*C2HF3O2

C146H185FN16O29S*C2HF3O2

B

C146H185FN16O29S*C2HF3O2

C146H185FN16O29S*C2HF3O2

Conditions
ConditionsYield
Stage #1: (3aS,4R,7S,9R,10R,11R,13R,15R)-1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyloctahydro-1H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(7H,9H)-tetraone; C103H122N10O20S With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 3h; Inert atmosphere;
Stage #2: trifluoroacetic acid In water-d2; acetonitrile
A 12%
B 13%

760981-83-7Downstream Products

760981-83-7Relevant articles and documents

Ribosome-Templated Azide-Alkyne Cycloadditions: Synthesis of Potent Macrolide Antibiotics by in Situ Click Chemistry

Glassford, Ian,Teijaro, Christiana N.,Daher, Samer S.,Weil, Amy,Small, Meagan C.,Redhu, Shiv K.,Colussi, Dennis J.,Jacobson, Marlene A.,Childers, Wayne E.,Buttaro, Bettina,Nicholson, Allen W.,MacKerell, Alexander D.,Cooperman, Barry S.,Andrade, Rodrigo B.

, p. 3136 - 3144 (2016)

Over half of all antibiotics target the bacterial ribosome-nature's complex, 2.5 MDa nanomachine responsible for decoding mRNA and synthesizing proteins. Macrolide antibiotics, exemplified by erythromycin, bind the 50S subunit with nM affinity and inhibit protein synthesis by blocking the passage of nascent oligopeptides. Solithromycin (1), a third-generation semisynthetic macrolide discovered by combinatorial copper-catalyzed click chemistry, was synthesized in situ by incubating either E. coli 70S ribosomes or 50S subunits with macrolide-functionalized azide 2 and 3-ethynylaniline (3) precursors. The ribosome-templated in situ click method was expanded from a binary reaction (i.e., one azide and one alkyne) to a six-component reaction (i.e., azide 2 and five alkynes) and ultimately to a 16-component reaction (i.e., azide 2 and 15 alkynes). The extent of triazole formation correlated with ribosome affinity for the anti (1,4)-regioisomers as revealed by measured Kd values. Computational analysis using the site-identification by ligand competitive saturation (SILCS) approach indicated that the relative affinity of the ligands was associated with the alteration of macrolactone+desosamine-ribosome interactions caused by the different alkynes. Protein synthesis inhibition experiments confirmed the mechanism of action. Evaluation of the minimal inhibitory concentrations (MIC) quantified the potency of the in situ click products and demonstrated the efficacy of this method in the triaging and prioritization of potent antibiotics that target the bacterial ribosome. Cell viability assays in human fibroblasts confirmed 2 and four analogues with therapeutic indices for bactericidal activity over in vitro mammalian cytotoxicity as essentially identical to solithromycin (1).

Synthesis, Biological Evaluation, and Computational Analysis of Biaryl Side-Chain Analogs of Solithromycin

Daher, Samer S.,Lee, Miseon,Jin, Xiao,Teijaro, Christiana N.,Wheeler, Steven E.,Jacobson, Marlene A.,Buttaro, Bettina,Andrade, Rodrigo B.

supporting information, p. 3368 - 3373 (2021/09/06)

There is an urgent need for new antibiotics to mitigate the existential threat posed by antibiotic resistance. Within the ketolide class, solithromycin has emerged as one of the most promising candidates for further development. Crystallographic studies of bacterial ribosomes and ribosomal subunits complexed with solithromycin have shed light on the nature of molecular interactions (π-stacking and H-bonding) between from the biaryl side-chain of the drug and key residues in the 50S ribosomal subunit. We have designed and synthesized a library of solithromycin analogs to study their structure-activity relationships (SAR) in tandem with new computational studies. The biological activity of each analog was evaluated in terms of ribosomal affinity (Kd determined by fluorescence polarization), as well as minimum inhibitory concentration assays (MICs). Density functional theory (DFT) studies of a simple binding site model identify key H-bonding interactions that modulate the potency of solithromycin analogs.

Method for preparing Solithromycin compound

-

, (2017/08/28)

The invention provides a method for preparing a macrolide antibiotic, namely Solithromycin. The method includes the steps of fluorination, side chain condensation, deprotection and the like or includes the steps of side chain condensation, fluorination, deprotection and the like. Time when triazole side chains large in polarity are introduced is late, the defect that purification is not easy is avoided, and cost of Solithromycin is also reduced.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 760981-83-7